Oxidation of reduced nicotinamide-adenine dinucleotide in muscle homogenates.
D000654:Amobarbital / Q000494:pharmacology; D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D003964:Diaphragm; D005459:Fluorides / Q000494:pharmacology; D006019:Glycolysis; D006027:Glycosides / Q000494:pharmacology; D006600:Hexosephosphates / Q000378:metabolism; D066298:In Vitro Techniques; D008928:Mitochondria / Q000378:metabolism; D009132:Muscles / Q000378:metabolism*; D009206:Myocardium / Q000378:metabolism; D009243:NAD / Q000378:metabolism*; D009840:Oligomycins / Q000494:pharmacology; D010088:Oxidoreductases; D051381:Rats
D006027:Glycosides; D006600:Hexosephosphates; D009840:Oligomycins; D009243:NAD; D000968:Antimycin A; D010088:Oxidoreductases; D000654:Amobarbital; D005459:Fluorides